In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital (Q36456932)

14 August 2017

In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital (English)

1 reference

14 August 2017

Cornaglia G

1

1 reference

14 August 2017

Pompei R

series ordinal

2

1 reference

14 August 2017

Dainelli B

series ordinal

3

1 reference

14 August 2017

Satta G

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

Antimicrobial Agents and Chemotherapy

14 August 2017

1 reference

14 August 2017

31

1 reference

14 August 2017

10

1 reference

14 August 2017

1651-1655

1 reference

Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

In vitro activity of ciprofloxacin (Bay o 9867)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Recognition of Group D Streptococcal Species of Human Origin by Biochemical and Physiological Tests

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

In vitro susceptibilities of four species of coagulase-negative staphylococci

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Simplified scheme for routine identification of human Staphylococcus species

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Comparative in-vitro activity of ciprofloxacin against non-fermenters.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175009

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3435111

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3435111

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.31.10.1651

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

3435111

1 reference